IMPLANET Raises Additional EUR 8 Million (USD 11 Million) to Fuel Deployment

IMPLANET Raises EUR 8 Million

BORDEAUX, France, April 26, 2010 - Thanks to promising commercial debut of its products (Surgical
implants for Orthopedic and Spine surgery) and its Healthcare Information
Technologies service offer (fully integrated and automated patient/product
tracking and supply chain) IMPLANET S.A. raises an additional EUR 8 million
(USD 11 million).

IMPLANET is proud to welcome a reference new institutional investor,
CM-CIC Private Equity which brings EUR 4 million.

Led by Edmond de Rothschild Investment Partners, historical
shareholders, Wellington Partners, Seventures Partners et Auriga Partners
along with founders, management and several domain reference private
investors such as Marie-Hélène PLAIS-COTREL (ex Sofamor-Danek) continue to
support IMPLANET since inception in 2007 and together provide EUR 4 million.

Erick CLOIX (CEO IMPLANET) declares: "This new round of
financing concludes a first cycle of 3 years during which 30 million Euros
were invested to prepare and develop a novel type of Healthcare Company
addressing, at last, the paradigm shifting challenges of quality, security
and financing of healthcare everywhere, particularly in Europe and the USA.
The current economic and financial crisis along with the US health care
reform in the USA is a catalyst for our technologies, our services and our
business model. The new 2010-2012 cycle which opens for us looks formidable
with opportunities and conquests."

About Implanet

Implanet is a Medical Device and Healthcare Information
Technology company based in Bordeaux, France. IMPLANET was incorporated in
early 2007 and currently employs 45 full time employees and is already
present within 8 countries. IMPLANET designs and manufactures surgical
implants (HIP, KNEE, SPINE, and ARTHROSCOPY) exclusively in France and in
Europe. These products are tested and registered under CE & FDA guidelines
and standards by independent US and French registered testing laboratories.
IMPLANET designs and develops unique healthcare information technologies
applications for the tracking and tracing of Medical devices/Drugs and
patients as well as healthcare supply chain optimization for both suppliers
and hospitals under the brand name BEEP N TRACK . IMPLANET is also sole
proprietor of various invention patents in France, Europe the USA and Asia on
its surgical products and its Information Technologies.

www.implanet.com/shareholder/levee_fond_en.pdf

www.implanet.com

www.beepntrack.com

www.edrip.fr

Stéphane MILOT, Tél: +33(0)5-57-99-55-77, smt at implanet.com; Nazanin SAHAMI, Tél: +33(0)5-56-03-13-15, nsi at beepntrack.com; Edmond de Rothschild Investment Partners, Raphaël Wisniewski, Tél: +33-1-40-17-31-44, raphael.wisniewski at lcfr.fr